Research and development of research and development of natural resources for the treatment of thrombotic stocks and chronic wounds (Q11201)

From EU Knowledge Graph
Revision as of 20:09, 6 June 2020 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Research and development of research and development of natural resources for the treatment of thrombotic stocks and chronic wounds
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    5,769,000.0 Czech koruna
    0 references
    230,760.0 Euro
    10 January 2020
    0 references
    15,384,000.0 Czech koruna
    0 references
    615,360.0 Euro
    10 January 2020
    0 references
    37.5 percent
    0 references
    12 May 2017
    0 references
    17 April 2020
    0 references
    VUAB Pharma a.s.
    0 references
    0 references

    50°9'46.91"N, 14°23'2.26"E
    0 references
    25263
    0 references
    Předmětem projektu je vývoj postupu přípravy vysoce účinných proteolytik (KR-X) z antarktického krillu, které budou použity v různých oborech medicíny. Výstupem, kromě technologických postupů přípravy, budou dva prototypy proteolytika KR-X - pro léčbu chronických ran a pro trombolýzu cévních trombů. Díky mechanismu působení enzymu na nežádoucí fibrin a fragmenty se předpokládá u pacientů lepší snášenlivost a nižší bolestivost léčby oproti agresívnějším enzymatickým prostředkům. a. (Czech)
    0 references
    The project concerns the development of a procedure for the preparation of highly effective proteolytics (KR-X) from Antarctic Krill, which will be used in the various fields of medicine. In addition to the preparation process, there will be two protypes Proteolytics KR-X — for the treatment of chronic wounds and for the thrombolysis of vascular thrombosis (KR-X). The mechanism of action of the enzyme on unwanted fibrin and fragments is expected to improve the degree of tolerance and pain of treatment in patients than the aggressive enzymatic means of treatment. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_083/0010108
    0 references